| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bd4ac3f93e3963fa50daef11c0835780
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9b6de434bd539d53f7644e1fa1d44acd |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2760-18422
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2760-18421
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2760-18423
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-5254
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-545
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2760-18434 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-005 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-93 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-45
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N7-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-155
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-14 |
| filingDate |
2022-03-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_40a6a5e353e45f9bc2d3c1ada3294b82
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5590ca7828a73b6d641329e8993ecbbf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9eda602b0b885373df278217a250feb4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_793113a364cf557cb7e0397f72472e7b |
| publicationDate |
2022-09-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2022188784-A1 |
| titleOfInvention |
Construction of h-gene-replaced chimeric measles attenuated strain |
| abstract |
Provided are a construction method for an H-gene-replaced chimeric measles attenuated strain and an application thereof. The attenuated strain is a measles virus rMV/H(H1a) having an accession number of CCTCCNO: V202074. Further provided are a vaccine composition containing the H-gene-replaced chimeric measles attenuated strain or a derivative virus strain thereof as an active ingredient, and a preparation method therefor. |
| priorityDate |
2021-03-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |